Bismuth complexes inhibit the SARS coronavirus

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

76 Scopus Citations
View graph of relations

Author(s)

  • Nan Yang
  • Julian A. Tanner
  • Bo-Jian Zheng
  • Rory M. Watt
  • Lin-Yu Lu
  • Jie-Qing Jiang
  • Ka-To Shum
  • Yong-Ping Lin
  • Kin-Ling Wong
  • Marie C. M. Lin
  • Hsiang-Fu Kung
  • Hongzhe Sun
  • Jian-Dong Huang

Detail(s)

Original languageEnglish
Pages (from-to)6464-6468
Journal / PublicationAngewandte Chemie - International Edition
Volume46
Issue number34
Publication statusPublished - 2007
Externally publishedYes

Abstract

Hold tight: Bismuth complexes including ranitidine bismuth citrate effectively inhibit the nucleoside triphosphate hydrolase and DNA unwinding activities of the SARS coronavirus (SCV) helicase and dramatically reduce SCV replication levels in infected cells. This suggests that bismuth-based drugs should be further evaluated for the treatment of SCV infections in vivo. ss = single-stranded DNA, ds = duplex DNA. (Figure Presented). © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.

Research Area(s)

  • Antiviral agents, Bismuth, Enzymes, Helical structures, SARS coronavirus

Citation Format(s)

Bismuth complexes inhibit the SARS coronavirus. / Yang, Nan; Tanner, Julian A.; Zheng, Bo-Jian et al.

In: Angewandte Chemie - International Edition, Vol. 46, No. 34, 2007, p. 6464-6468.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review